Gatekeepers of Knowledge: How Proprietary Research Materials Are Fracturing the Scientific Commons

Science has long presented itself as a universal enterprise — one in which ideas are tested, findings are shared, and knowledge accumulates without regard for institutional pedigree or geography. That self-image, however, grows harder to sustain when a researcher at a mid-tier state university must spend months negotiating material transfer agreements with an elite coastal institution, only to receive a partial dataset stripped of the metadata that would make it useful. The formal mechanisms of scientific exchange remain intact; the functional reality is considerably more constrained.

The concentration of proprietary control over research materials — spanning human tissue biobanks, proprietary cell lines, closed software repositories, and curated experimental datasets — is generating what some scholars of science policy now describe as structural dead zones: regions of inquiry that are technically open to investigation but practically inaccessible to the majority of researchers worldwide, and disproportionately to those outside a small cluster of well-resourced American and European institutions.

The Architecture of Exclusion

The mechanisms through which access is restricted are varied, and not all are the product of deliberate bad faith. Material Transfer Agreements, or MTAs, are standard legal instruments governing the sharing of biological samples and reagents. In principle, they protect intellectual property and ensure appropriate attribution. In practice, their negotiation can consume months of administrative labor, impose onerous publication restrictions, and include sublicensing clauses that effectively prevent downstream collaboration. A 2021 survey of biomedical researchers published in PLOS ONE found that nearly 40 percent of respondents had abandoned a planned study because MTA negotiations proved prohibitively time-consuming or restrictive.

Code repositories present a parallel problem. While platforms such as GitHub have made software sharing technically straightforward, the code underlying many published studies remains either unavailable or available only in forms that cannot be meaningfully executed. Dependencies go undocumented. Proprietary software licenses block reuse. Version histories are scrubbed before publication. The result is a scientific literature populated with methods sections that describe computational workflows that cannot, in practice, be reproduced without direct access to the originating laboratory's internal systems.

Datasets occupy perhaps the most contested terrain. Funding agencies including the National Institutes of Health and the National Science Foundation have strengthened data-sharing mandates in recent years, and the 2023 NIH Data Management and Sharing Policy represented a meaningful step toward open access. Yet compliance remains uneven, and the datasets that are shared are frequently deposited in formats that serve the depositing institution's internal conventions rather than the broader research community's needs.

Geographic and Institutional Fault Lines

The distributional consequences of these practices are not random. Researchers at institutions with robust legal and administrative infrastructure — the major research universities concentrated along the coasts and in select Midwestern cities — are better positioned to negotiate access agreements, maintain the computational environments required to run shared code, and absorb the overhead costs of data acquisition. Researchers at historically Black colleges and universities, regional comprehensive universities, and institutions in rural states operate under fundamentally different constraints.

International disparities compound domestic inequalities. Collaborative agreements that American institutions maintain with peer institutions in Western Europe or East Asia are rarely extended with equivalent generosity to researchers in sub-Saharan Africa, South Asia, or Latin America. The irony is acute: populations that are medically underrepresented in existing datasets are often located in precisely the regions that face the greatest barriers to contributing new data or accessing existing collections.

The downstream effects on innovation are difficult to quantify precisely but are not difficult to observe. When only a narrow cohort of institutions can engage with a given body of research materials, the range of hypotheses tested, the diversity of methodological approaches applied, and the breadth of populations considered all contract. Scientific progress becomes path-dependent in ways that reflect the priorities of a small number of funders and institutions rather than the full scope of unanswered questions.

Case Studies in Closed Science

The challenges are not hypothetical. Consider the landscape of human genomic research. The major biobanks — the UK Biobank, the NIH's All of Us program, and several large academic medical center repositories — hold data of extraordinary scientific value. Access to these resources, however, is mediated through application processes that require institutional affiliations, data use agreements, and in some cases fees that are nominal for well-funded laboratories but prohibitive for independent researchers or those at resource-constrained institutions.

In computational biology, the problem of inaccessible code has been documented extensively. A 2020 study examining papers published in leading journals found that a majority of studies claiming to provide open-source code linked to repositories that were either empty, incomplete, or contained files that could not be executed without contacting the original authors. The authors of that study noted, with some understatement, that the current norm of "available upon request" functions less as a sharing mechanism than as a deferral strategy.

In materials science and chemistry, proprietary control over synthesis protocols and precursor compounds has created situations in which published results cannot be independently verified because the materials required to attempt verification are held exclusively by the originating laboratory or its commercial partners.

Emerging Policy Responses

The policy environment is not static. The Biden administration's 2022 guidance memo on federally funded research, which expanded open-access requirements for publications, signaled a broader federal disposition toward openness that has begun to extend to research materials. Several major private foundations, including the Gates Foundation and the Wellcome Trust, have adopted materials-sharing requirements as conditions of grant funding.

Within the academic community, preregistration platforms and open-science frameworks have created infrastructure that, if adopted at scale, would make gatekeeping considerably more difficult to sustain. The Center for Open Science and similar organizations have worked to establish norms and technical standards that lower the barriers to genuine sharing.

Yet infrastructure and policy alone are insufficient if the incentive structures that reward exclusivity remain unchanged. Tenure and promotion criteria at most American research universities continue to reward publications and grant revenue over data stewardship and collaborative openness. Until sharing is valued as a professional contribution in its own right — and until institutions bear reputational costs for systematic gatekeeping — policy mandates will be observed in form while being circumvented in practice.

Toward a Genuine Scientific Commons

The concept of a scientific commons — a shared reservoir of knowledge and materials accessible to any qualified investigator — is foundational to the self-understanding of the research enterprise. Realizing that concept in practice requires confronting the ways in which institutional interests, legal frameworks, and professional incentives have collectively constructed a system that concentrates access rather than distributing it.

The policy tools are available. Standardized, machine-readable MTAs that reduce negotiation overhead; tiered access models that provide broader availability to researchers at resource-constrained institutions; funding requirements that condition grant renewal on verified sharing compliance; and promotion criteria that treat data stewardship as a measurable scholarly contribution — each of these represents a tractable intervention.

What remains to be determined is whether the institutions and funders that benefit most from the current arrangement possess the will to dismantle it. The scientific community's commitment to universal inquiry will ultimately be measured not by its stated ideals but by the structural choices it makes about who is permitted to participate.